Abstract
Micro-Abstract Asymmetric increase in breast vascularity (AIBV) is an emerging marker in magnetic resonance imaging-based evaluation of breast cancer. We analyze herein the largest series so far aimed at elucidating the potential role of AIBV in predicting the early and late outcomes of locally advanced breast cancer. We observed that, despite more aggressive pathologic profile of tumors associated with AIBV, they also present greater sensitivity to neoadjuvant chemotherapy. Nonetheless, the persistence of AIBV after neoadjuvant chemotherapy is associated with worse late prognosis and might be used to tailor additional treatments.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | e193-e201 |
| Numero di pagine | 9 |
| Rivista | Clinical Breast Cancer |
| Volume | 16 |
| Numero di pubblicazione | 6 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2016 |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
-
SDG 3 Salute e benessere
All Science Journal Classification (ASJC) codes
- Oncologia
- Ricerca sul Cancro
Keywords
- Breast tumor
- Cancer Research
- Increased vascularization
- Magnetic Resonance Imaging
- Neoadjuvant chemotherapy
- Oncology
- Prognosis
Fingerprint
Entra nei temi di ricerca di 'Hypervascularity Predicts Complete Pathologic Response to Chemotherapy and Late Outcomes in Breast Cancer'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver